News

Professor Fred Apple Reveals Another Significant Progress with Mindray in Cardiac Biomarkers At ADLM 2025

Mindray’s new hs-cTnI assay, validated by Prof. Fred Apple at ADLM 2025, delivers breakthrough sensitivity for distinguishing acute vs chronic myocardial injury and Type 1 vs Type 2 MI—setting new standards in emergency cardiac diagnostics.

Events | In-Vitro Diagnostics | Cardiology | Smart applications | Biochemistry | Reagent | Digitalization 2025-08-01
"Chinese Innovation" Shines Again at Top North American Conference

Mindray’s Long-T ITC reagent, honored at ADLM 2025, delivers AUC 0.959 performance—outperforming hs-cTnT—enabling single-test MI rule-out for 52 % of patients with ≥0.993 sensitivity.

In-Vitro Diagnostics | Chemiluminescence immunoassay | Cardiology | Awards & Recognitions 2025-08-01
From Athens to Casablanca: Health Talks via MiCo+ at Nuewa Clubs

Addressing global healthcare gaps: Mindray’s MiCo+ platform enables real-time academic exchanges between Europe and Africa, enhancing maternal and fetal care through innovative cloud technology and high-definition ultrasound.

Ultrasound | Smart applications | Events | Nuewa Club | OB GYN | Digitalization 2025-07-18
Project 2025 | Shaping the Future of Ultrasound Education Together

Mindray’s Project 2025 is revolutionizing ultrasound education through global training centers and partnerships. Discover how this initiative has empowered 10,000 medical professionals with advanced ultrasound skills.

Ultrasound | Education | Events | Globalization 2025-06-24
Estradiol (E2) Detection Highlighted at EuroMedLab 2025: SEMS Technology Elevating Hormone Detection

Explore SEMS technology at EuroMedLab 2025: A breakthrough for estradiol detection with precision comparable to mass spectrometry. Learn how it enhances breast cancer endocrine therapy and hormone diagnostics.

Events | In-Vitro Diagnostics | Smart applications | Digitalization | Hematology 2025-05-30
A Glimpse from EuroMedLab 2025: PRL Workshop Unveils Breakthroughs in Prolactin Detection

Discover Mindray’s groundbreaking PRL assay at IFCC-EFLM EuroMedLab 2025. With strong resistance to macroprolactin interference, this innovation enhances the precision of hyperprolactinemia diagnosis through advanced AI and antibody engineering.

Events | In-Vitro Diagnostics 2025-05-27
Mindray Showcasing Its Commitment to Smart Healthcare Technology in Brazil

See how Mindray’s smart healthcare technologies are enhancing efficiency and diagnostics in Brazilian hospitals. From AI-driven tools to hospital-wide integration, explore the future of healthcare at Hospitalar 2025.

Hospitalwide solution | Digitalization | Events 2025-05-24
Bringing more smiles to children - Mindray Italy raises €9441 for the charity partner, Operation Smile Italia ETS

Mindray Italy raises €9,441 for Operation Smile Italia ETS via #MilesForSmiles challenge. Learn how their 10-year partnership supports healthcare access in low-income communities with advanced medical expertise.

Operation Smile | CSR | Donation 2025-05-13
Mindray at ECR 2025: Takes Ultrasound Imaging to a New Level

Mindray takes ultrasound imaging to new heights at ECR 2025 with the Resona A20, featuring Acoustic Intelligence Technology and innovative tools for precise diagnosis and clinical research, while emphasizing sustainability.

Ultrasound | Academic 2025-03-06
Mindray Partners with Center for Medical Simulation to Launch Inaugural VeriSiM+ Training Course in Boston

Learn about the VeriSiM+ program, designed by Harvard faculty to equip healthcare professionals with advanced simulation training concepts, using Mindray's cutting-edge equipment for realistic clinical scenarios.

Patient monitoring | Education | Partnerships | Anesthesiology 2025-01-24

Load more